BCAL Diagnostics

BCAL Diagnostics Acquisitions (Net)

The Acquisitions (Net) of BCAL Diagnostics (BDX.AX) as of Oct 17, 2026 is 4.00 M AUD. In the previous year, Acquisitions (Net) was -4.00 M AUD — a change of -200.00% (higher).

Acquisitions (Net)

4.00 MAUD

YoY

-200.00%

Last updated:

Acquisitions (Net) of BCAL Diagnostics is 2023 4.00 M AUD. Acquisitions (Net) of BCAL Diagnostics was 2022 -4.00 M AUD. It decreases by -200.00% higher compared to the previous year.

The BCAL Diagnostics Acquisitions (Net) history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Acquisitions (Net)
Date
Acquisitions (Net)
Jan 1, 2018
-100.00 AUD
Jan 1, 2022
-4.00 M AUD
Jan 1, 2023
4.00 M AUD
The BCAL Diagnostics Acquisitions (Net) history
YEARAcquisitions (Net)YoY
4.00 MAUD-200.00%
-4.00 MAUD+4.00 M%
-100.00AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BCAL Diagnostics Stock analysis

What does BCAL Diagnostics do? BCAL Diagnostics Ltd, based in Sydney, Australia, operates in the Health Care sector within the Biotechnology industry. The company develops innovative blood screening tests for early breast cancer detection, focusing on a lipid biomarker-based approach known as the BCAL test. This technology complements existing imaging methods like mammograms and aims to support screening and monitoring for women of all ages and backgrounds. BCAL Diagnostics has partnered with Precion Inc. to advance clinical trials and regulatory approvals for its diagnostic solutions. BCAL Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BCAL Diagnostics stock

Acquisitions (Net) of BCAL Diagnostics is 4.00 M AUD in 2023.

Acquisitions (Net) of BCAL Diagnostics changed from -4.00 M AUD to 4.00 M AUD, representing a -200.00% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Acquisitions (Net) BCAL Diagnostics since 2006 – with annual values, charts, and detailed analysis.

Net acquisitions represent the cash spent on acquiring other businesses, net of divestitures. Large acquisitions can transform a company's growth trajectory.

Acquisitions (Net)'s AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Acquisitions (Net)'s BCAL Diagnostics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — BCAL Diagnostics

All Key Metrics — BCAL Diagnostics